Recombinant E. coli Methyl Ketone Production Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing medium-chain length methyl ketones are inefficient and lack effective technologies for scalable production, limiting their availability for biological and industrial applications such as pheromones, flavors, and diesel fuels.
Innovation Solution
Recombinant cells, specifically engineered E. coli, are developed to produce methyl ketones like 2-heptanone, 2-nonanone, and 2-undecanone through genetic modifications involving recombinant β-ketoacyl-CoA thioesterase, acyl-ACP thioesterase, and acyl-CoA synthetase genes, along with functional deletions of native genes to enhance production pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used for producing methyl ketones, then production is possible, but efficiency and scalability are insufficient
Solution Approach 1:
The invention segments the methyl ketone production pathway into distinct enzymatic steps, each catalyzed by a specific recombinant enzyme (β-ketoacyl-CoA thioesterase, acyl-ACP thioesterase, acyl-CoA synthetase). This segmentation allows for optimized expression of each enzyme component and enables modular pathway construction that can be scaled independently, resolving the contradiction between production efficiency and scalability.
Solution Approach 2:
The invention changes key parameters of the production system by using recombinant DNA technology to overexpress specific enzymes at controlled levels. By adjusting expression levels, induction conditions, and host cell physiology, the system achieves high production efficiency while maintaining scalability through standardized bioprocessing parameters.
2Productivity
If native gene deletions are performed to enhance production pathways, then methyl ketone production is improved, but cell functionality may be compromised
Solution Approach 1:
The invention extracts and removes specific native genes (fadR, fadE, fadB, fadJ) that compete with or repress the methyl ketone production pathway. By taking out these interfering genetic elements, the system enhances methyl ketone production while maintaining cell viability through careful selection of deletions that remove only pathway-blocking functions rather than essential cellular processes.
Solution Approach 2:
The invention introduces recombinant enzyme genes as intermediaries that mediate the conversion of fatty acid substrates to methyl ketone products. These intermediary enzymes (β-ketoacyl-CoA thioesterase, acyl-ACP thioesterase, acyl-CoA synthetase) bridge the gap between native metabolic pathways and desired product formation, enabling high productivity without compromising overall cell function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered recombinant cells significantly increase the production of medium-chain methyl ketones, achieving higher titers and improving the efficiency of methyl ketone synthesis, making them suitable for industrial applications.
Implementation Method 1
A recombinant cell of the invention comprises a recombinant β-ketoacyl-CoA thioesterase gene... encodes a FadM protein... The engineered recombinant cells significantly increase the production of medium-chain methyl ketones
Implementation Method 2
a recombinant acyl-ACP thioesterase gene... encodes a protein comprising an amino acid sequence with at least 80%... sequence identity to SEQ ID NO:2 or SEQ ID NO:4
Implementation Method 3
a recombinant acyl-CoA synthetase gene... encodes a FadD protein... The engineered recombinant cells significantly increase the production of medium-chain methyl ketones
Data Source
AI summary
Recombinant cells and methods for producing methyl ketones, such as medium-chain methyl ketones. The recombinant cells include recombinant acyl-ACP thioesterase genes, recombinant β-ketoacyl-CoA thioesterase genes, and recombinant acyl-CoA synthetase genes, in addition to other modifications. The methods include culturing the recombinant cells to produce the methyl ketones and isolating the produced methyl ketones.